20317-40-2

Basic information

• Product Name: METHYL 4-ISOQUINOLINECARBOXYLATE
• Synonyms: METHYL 4-ISOQUINOLINECARBOXYLATE;4-Isoquinolinecarboxylic acid, methyl ester;methyl isoquinoline-4-carboxylate
• CAS NO: 20317-40-2
• Molecular Formula: C₁₁H₉NO₂
• Molecular Weight: 187.19
• Mol File: 20317-40-2.mol

Chemical Properties

• Melting Point: 82℃
• Boiling Point: 315.263°C at 760 mmHg
• Flash Point: 144.466°C
• Appearance: /
• Density: 1.21g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.615
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 3.30±0.10(Predicted)
• CAS DataBase Reference: METHYL 4-ISOQUINOLINECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-ISOQUINOLINECARBOXYLATE(20317-40-2)
• EPA Substance Registry System: METHYL 4-ISOQUINOLINECARBOXYLATE(20317-40-2)

Safety Data

• Hazardous Substances Data: 20317-40-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 4-ISOQUINOLINECARBOXYLATE is used as a key intermediate for the synthesis of various drugs, leveraging its chemical properties to contribute to the development of new therapeutic agents.
Used in Organic Synthesis:
METHYL 4-ISOQUINOLINECARBOXYLATE is used as a building block for creating new compounds and materials, allowing for the exploration of its diverse properties and potential applications in various fields.
Used in Research and Development:
METHYL 4-ISOQUINOLINECARBOXYLATE is used as a subject of study for its potential therapeutic applications, particularly in exploring its antitumor and anti-inflammatory properties, with the aim of advancing medical treatments and interventions.

InChI:InChI=1/C11H9NO2/c1-14-11(13)10-7-12-6-8-4-2-3-5-9(8)10/h2-7H,1H3

Upstream product

• 67-56-1 methanol 
• 34846-65-6 isoquinoline-4-carbonitrile 
• 685103-98-4 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline 
• 201230-82-2 carbon monoxide 
• 119-65-3 isoquinoline 
• 7159-36-6 4-isoquinolinecarboxylic acid 
• 34784-02-6 3-bromoisoquinoline 
• 1532-97-4 4-bromoisoquinoline 
• 370580-85-1 C₁₀H₆ClNO 

Downstream Products

• 116140-19-3 1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid 

Relevant articles and documents

Pd(0)-mediated [11C]carbonylation of aryl and heteroaryl boronic acid pinacol esters with [11C]carbon monoxide under ambient conditions and a facile process for the conversion of [carbonyl-11C]esters to [carbonyl-11C]amides

A new method has been developed for the Pd(0)-mediated [11C]carbonylation of aryl/heteroaryl boronic acid pinacol esters with [11C]carbon monoxide in the presence of p-benzoquinone and triphenylphosphine in a mixture of N,N-dimethylformamide (DMF) and methanol (MeOH) or just MeOH under ambient pressure at 65 °C. This method was used to convert a variety of different aryl/heteroaryl boronates to the corresponding [carbonyl-11C]esters with decay-corrected radiochemical yields in the range of 6-80%. Furthermore, some of these [carbonyl-11C]esters were treated with sodium hydroxide or aqueous ammonium to give the corresponding [carbonyl-11C]carboxylic acids and amides, respectively. This new method was also used to achieve the direct syntheses of [11C]aspirin using water or tetramethylammonium hydroxide as the nucleophile instead of MeOH in DMF.

CANNABINOID RECEPTOR MODULATORS

Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of cannabinoid (CB) receptors. Methods of treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of cannabinoid (CB) receptors of Formula (I).

Palladium-catalyzed carbonylation reactions of aryl bromides at atmospheric pressure: A general system based on xantphos

(Chemical Equation Presented) A method for the Pd-catalyzed carbonylation of aryl bromides has been developed using Xantphos as the ligand. This method is effective for the direct synthesis of Weinreb amides, 1° and 2° benzamides, and methyl esters from the corresponding aryl bromides at atmospheric pressure. In addition, a putative catalytic intermediate, (Xanphos)Pd(Br)benzoyl, was prepared and an X-ray crystal structure was obtained revealing an unusual cis-coordination mode of Xantphos in this palladium-acyl complex.

NOVEL ANABASEINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

Disclosed are novel anabaseine derivatives that act as agonists of the α7 nAChR. Also disclosed are pharmaceutical compositions, methods- of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from

A Unified Synthesis of Bifunctional 4-Substituted-1,2,3,4-tetrahydroisoquinoline Derivatives

Starting from a single, commercially available bromoisoquinoline, convenient (multigram) syntheses of 4-substituted-1,2,3, 4-tetrahydroisoquinoline derivatives have been developed. The compounds thus prepared show suitable substitution patterns for further derivatization and constitute a new family of compounds of potential pharmacological interest.